We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

148 hedge funds and large institutions have $839M invested in Cardiovascular Systems, Inc. in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 49

3% more call options, than puts

Call options by funds: $486K | Put options by funds: $473K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 159148 (-11)

26% less capital invested

Capital invested by funds: $1.13B → $839M (-$288M)

36% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 28

Holders
148
Holders Change
-11
Holders Change %
-6.92%
% of All Funds
3.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
59
Reduced
49
Closed
28
Calls
$486K
Puts
$473K
Net Calls
+$13K
Net Calls Change
+$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
1
Brown Capital Management
Maryland
$103M +$7.01M +220,714 +7%
BlackRock
2
BlackRock
New York
$82.7M +$10.3M +322,994 +13%
CIP
3
Champlain Investment Partners
Vermont
$73.8M +$6.3M +198,300 +8%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$59.9M +$4.55M +143,371 +7%
Vanguard Group
5
Vanguard Group
Pennsylvania
$47.4M +$3.58M +112,551 +7%
PHS
6
PFM Health Sciences
California
$45.6M +$18.5M +581,950 +57%
State Street
7
State Street
Massachusetts
$32.2M -$243K -7,646 -0.7%
Renaissance Technologies
8
Renaissance Technologies
New York
$29.8M +$5.08M +159,944 +18%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$23.8M +$402K +12,645 +2%
FCM
10
Frontier Capital Management
Massachusetts
$20.3M -$1.09M -34,183 -5%
CAM
11
Cortina Asset Management
Wisconsin
$19.4M -$610K -19,190 -3%
BM
12
Bridger Management
New York
$15.3M +$2.17M +68,336 +15%
New York State Common Retirement Fund
13
New York State Common Retirement Fund
New York
$14.9M -$159K -5,000 -0.9%
Norges Bank
14
Norges Bank
Norway
$14.3M +$831K +26,164 +6%
FLAM
15
First Light Asset Management
Minnesota
$13.7M -$74.7K -2,350 -0.5%
Northern Trust
16
Northern Trust
Illinois
$13M +$357K +11,234 +3%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$11.9M -$524K -16,500 -4%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$11.1M +$1.04M +32,780 +9%
GIM
19
Granahan Investment Management
Massachusetts
$9.94M -$262K -8,241 -2%
TA
20
Teachers Advisors
New York
$9.14M +$91.8K +2,890 +0.9%
Millennium Management
21
Millennium Management
New York
$7.39M -$5.78M -182,029 -41%
Invesco
22
Invesco
Georgia
$7.25M +$463K +14,588 +6%
GF
23
Gabelli Funds
New York
$6.78M +$1.05M +33,066 +16%
Citadel Advisors
24
Citadel Advisors
Florida
$6.61M -$147K -4,631 -2%
GKIM
25
GW&K Investment Management
Massachusetts
$6.46M -$399K -12,575 -5%

CSII Hedge Fund Activity: Q4 2018 in Review

148 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2018, worth a combined $839M — down 26% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of CSII and 18 opened new positions — a net loss of 10 holders — while 49 trimmed existing stakes and 59 added.

The largest buyer was PFM Health Sciences, adding an estimated $18.5M. The largest seller was Deutsche Bank, cutting an estimated $17.2M.

  • 148 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2018, down from 159 in Q3 2018.
  • Funds reported $839M of Cardiovascular Systems, Inc. stock for Q4 2018, down 26% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q4 2018 and 28 closed out, a net change of -10 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2018 was PFM Health Sciences, an estimated $18.5M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2018 was Deutsche Bank, an estimated $17.2M sold.

Based on aggregated 13F filings for Q4 2018.